Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/123429
Full metadata record
DC FieldValueLanguage
dc.creatorStephanie Andrade
dc.creatorMaria J. Ramalho
dc.creatorJoana A. Loureiro
dc.creatorMaria do Carmo Pereira
dc.date.accessioned2020-05-27T23:08:13Z-
dc.date.available2020-05-27T23:08:13Z-
dc.date.issued2019
dc.identifier.issn0927-7765
dc.identifier.othersigarra:362566
dc.identifier.urihttps://hdl.handle.net/10216/123429-
dc.description.abstractNatural compounds such as caffeine (CA), gallic acid (GA) and tannic acid (TA) have been reported to be useful for Alzheimer's disease (AD) therapy. It was proved that some natural compounds inhibit the formation of senil plaques composed by beta-amyloid peptide (A beta), a hallmark of AD. Evidences suggest that the therapeutic activity of compounds depends of their interaction with biological membranes. To understand why these compounds fail in vivo and in clinical trials, it is important to evaluate their pharmacokinetics properties. Thus, a biophysical approach to study drug-membrane interactions is essential to understand the mechanisms by which the drugs interact with the cellular membranes and affect the A beta production, aggregation and clearance pathways. 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and cholesterol (chol) were used to mimic the biophysical properties of cell membranes and study their interactions with these compounds. The partition coefficient, influence on membrane fluidity and location within the bilayer of the drugs were studied by derivative spectrophotometry, dynamic light scattering and fluorescence quenching, respectively.
dc.language.isoeng
dc.relationinfo:eu-repo/grantAgreement/Comissão de Coordenação e Desenvolvimento Regional do Norte/P2020|Norte2020-Projetos Integrados ICDT/NORTE-01-0145-FEDER-000005/LEPABE-2-ECO-INNOVATION/LEPABE-2-ECO-INNOVATION
dc.relationinfo:eu-repo/grantAgreement/FCT - Fundação para a Ciência e Tecnologia/Programa de Financiamento Plurianual de Unidades de I&D/UID/EQU/00511/2019 /Projeto Estratégico do LEPABE - Laboratório de Engenharia de Processos, Ambiente, Biotecnologia e Energia/LEPABE
dc.rightsrestrictedAccess
dc.titleInteraction of natural compounds with biomembrane models: A biophysical approach for the Alzheimer's disease therapy
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoFaculdade de Engenharia
dc.identifier.doi10.1016/j.colsurfb.2019.04.019
Appears in Collections:FEUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
362566.pdf
  Restricted Access
1.07 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.